Robeco Institutional Asset Management
CMD

Robeco Institutional Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Robeco Institutional Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,382
Closed -$234K – 996
2018
Q2 		$234K Hold
2,382
– – ﹤0.01% 890
2018
Q1 		$265K Buy
+2,382
New +$267K ﹤0.01% 864

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Robeco Institutional Asset Management's CMD Position: Q3 2018 in Review

Robeco Institutional Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 2,382 shares — an estimated $234K sold.

Robeco Institutional Asset Management first reported a position in CMD in Q1 2018 and held it in 2 quarters. The position peaked at $265K in Q1 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Robeco Institutional Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 2,382 Cantel Medical Corporation shares in Q3 2018, an estimated $234K.
  • Robeco Institutional Asset Management first reported a position in Cantel Medical Corporation in Q1 2018 and held it in 2 quarters.
  • Robeco Institutional Asset Management's Cantel Medical Corporation position peaked at $265K in Q1 2018.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2018, filed 25 Oct 2018.